Facebook
Twitter
Telegram
Report an ErrorOncternal Therapeutics Cash Flow 2011-2024 | ONCT
Annual Cash Flow Oncternal Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-32.2 M | -36.7 M | -26.6 M | -17.5 M | -16.7 M | -7.42 M | -23.5 M | -20.8 M | -20 M | -28.8 M | -44 M | -37.1 M | -33.1 M |
Depreciation & Amortization |
- | - | - | - | - | 46 K | 47 K | 28 K | 43 K | 102 K | 384 K | 750 K | 1.04 M |
Accounts Payables |
1.15 M | 2.92 M | 1.96 M | 1.14 M | 871 K | 3.28 M | 2.6 M | 1.22 M | 382 K | 512 K | 808 K | 1.71 M | 1.22 M |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | 981 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | 161 K |
All numbers in USD currency
Quarterly Cash Flow Oncternal Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-7.44 M | - | - | - | -11 M | - | -27.7 M | -15.7 M | -8.61 M | - | -20 M | -13.6 M | -5.98 M | - | -13.6 M | -8.26 M | -4.04 M | - | -13.7 M | -9.87 M | -3.63 M | - | -5.15 M | -5.28 M | -11.1 M | - | -13.7 M | -10.4 M | -5.2 M | - | -15.5 M | -9.27 M | -4.78 M | - | -14.8 M | -9.86 M | -4.7 M | - | -23.7 M | -18 M | -8.09 M | - | -36.3 M | -25.3 M | -13.9 M | - | -27 M | -18.4 M | -10.5 M | - | -24.5 M | -16.6 M | -9.23 M |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11 K | - | - | - | 11 K | - | 35 K | 23 K | 12 K | - | 17 K | 9 K | 4 K | - | 36 K | 29 K | 17 K | - | 86 K | 65 K | 33 K | - | 333 K | 262 K | 150 K | - | 596 K | 413 K | 210 K | - | 819 K | 586 K | 318 K |
Accounts Payables |
1.46 M | 1.15 M | 2.13 M | 2.22 M | 1.96 M | 2.92 M | 2.46 M | 2.52 M | 2.4 M | 1.96 M | 2.75 M | 1.01 M | 1.89 M | 1.14 M | 1.14 M | 1.14 M | 1.14 M | 871 K | 871 K | 871 K | 871 K | 3.44 M | 3.44 M | 3.44 M | 3.28 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 1.22 M | 1.22 M | 1.22 M | 1.22 M | 382 K | 382 K | 382 K | 382 K | 512 K | 512 K | 512 K | 512 K | 808 K | 808 K | 808 K | 808 K | 1.71 M | 1.71 M | 1.71 M | 1.71 M | 1.22 M | 1.22 M | 1.22 M | 1.22 M |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9 K | 1.15 M | 908 K | 925 K | 981 K | 981 K | 981 K | 981 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 105 K | 146 K | 161 K | 161 K | 161 K | 161 K |
All numbers in USD currency